1
|
Lack of nephrotoxicity by 6% hydroxyethyl starch 130/0.4 during hip arthroplasty: a randomized controlled trial.
|
Anesthesiology
|
2014
|
3.24
|
2
|
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction.
|
Eur J Heart Fail
|
2005
|
1.64
|
3
|
The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial.
|
Anesth Analg
|
2015
|
1.08
|
4
|
Abnormally increased endothelin-1 in plasma during the night in obstructive sleep apnea: relation to blood pressure and severity of disease.
|
Am J Hypertens
|
2007
|
1.06
|
5
|
Blood pressure control during telemonitoring of home blood pressure. A randomized controlled trial during 6 months.
|
Blood Press
|
2008
|
0.99
|
6
|
Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects.
|
Am J Physiol Renal Physiol
|
2008
|
0.99
|
7
|
Effect of high and low sodium intake on urinary aquaporin-2 excretion in healthy humans.
|
Am J Physiol Renal Physiol
|
2011
|
0.89
|
8
|
Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man.
|
Clin Exp Hypertens
|
2012
|
0.86
|
9
|
Catheter-based renal denervation for treatment of resistant hypertension.
|
Dan Med J
|
2012
|
0.84
|
10
|
Abnormal increase in urinary aquaporin-2 excretion in response to hypertonic saline in essential hypertension.
|
BMC Nephrol
|
2012
|
0.84
|
11
|
Effect of amiloride and spironolactone on renal tubular function, ambulatory blood pressure, and pulse wave velocity in healthy participants in a double-blinded, randomized, placebo-controlled, crossover trial.
|
Clin Exp Hypertens
|
2012
|
0.83
|
12
|
Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans.
|
Nephrol Dial Transplant
|
2007
|
0.82
|
13
|
Urinary excretion of AQP2 and ENaC in autosomal dominant polycystic kidney disease during basal conditions and after a hypertonic saline infusion.
|
Am J Physiol Renal Physiol
|
2012
|
0.82
|
14
|
Effects of atorvastatin on systemic and renal nitric oxide in healthy man.
|
Clin Exp Hypertens
|
2012
|
0.81
|
15
|
Down-regulation of urinary AQP2 and unaffected response to hypertonic saline after 24 hours of fasting in humans.
|
Kidney Int
|
2005
|
0.80
|
16
|
Effect of vasopressin antagonism on renal handling of sodium and water and central and brachial blood pressure during inhibition of the nitric oxide system in healthy subjects.
|
BMC Nephrol
|
2014
|
0.79
|
17
|
Economic evaluation of home blood pressure telemonitoring: a randomized controlled trial.
|
Blood Press
|
2010
|
0.79
|
18
|
[Nephrogen systemic fibrosis is reported in a dialysis patient after MR-angiography with a contrast medium].
|
Ugeskr Laeger
|
2008
|
0.77
|
19
|
Effects of atorvastatin on systemic and renal NO dependency in patients with non-diabetic stage II-III chronic kidney disease.
|
Br J Clin Pharmacol
|
2014
|
0.76
|
20
|
Associations of objectively measured physical activity and abdominal fat distribution.
|
Med Sci Sports Exerc
|
2015
|
0.76
|
21
|
Effects of dihydralazine on renal water and aquaporin-2 excretion in humans.
|
Scand J Clin Lab Invest
|
2009
|
0.75
|
22
|
[Lithium can be given to patients on haemodialysis treatment].
|
Ugeskr Laeger
|
2015
|
0.75
|
23
|
[Acute oliguric renal failure and haemolytic anaemia following infectious mononucleosis].
|
Ugeskr Laeger
|
2015
|
0.75
|
24
|
[Improved prognosis of cystinosis achieved by treatment with cysteamine and by kidney transplantation].
|
Ugeskr Laeger
|
2011
|
0.75
|
25
|
Urinary aquaporin-2 excretion before and after transjugular intrahepatic portosystemic shunt insertion for refractory ascites.
|
Scand J Gastroenterol
|
2015
|
0.75
|
26
|
[High doses of aldosterone antagonist is a condition of sufficient blood pressure control in bilateral adrenal hyperplasia].
|
Ugeskr Laeger
|
2015
|
0.75
|
27
|
Transjugular intrahepatic portosystemic shunt: impact on systemic haemodynamics and renal and cardiac function in patients with cirrhosis.
|
Am J Physiol Gastrointest Liver Physiol
|
2017
|
0.75
|
28
|
[Genetics and hypertension].
|
Ugeskr Laeger
|
2009
|
0.75
|
29
|
Renal effects of urodilatin in healthy subjects are independent of blockade of the cyclooxygenase and angiotensin II receptor.
|
Scand J Clin Lab Invest
|
2007
|
0.75
|
30
|
[Improved prognosis in light chain nephropathy due to multiple myeloma].
|
Ugeskr Laeger
|
2012
|
0.75
|